Skip to content
Unrated Medical device recall · FDA · Published April 1, 2020

Abbott ARCHITECT C Peptide Calibrator Recall: Mexico License Error

Abbott recalls ARCHITECT C Peptide Calibrators due to Mexico license renewal documentation error. All units until new license is obtained are affected. No immediate action needed.

🇺🇸 FDA recall #Z-1894-2020Medical deviceAbbott ›
Take action

Contact the company

Recalling firmAbbott Laboratories100 Abbott Park Rd Bldg Ap8b · Abbott Park, IL 60064-3502
✎ GovInfoNow plain-language explainer

Abbott is recalling ARCHITECT C Peptide Calibrators because of a Mexico license renewal documentation error. This affects all units until a new license is obtained, but no action is required at this time. Read more at govinfonow.com/recall/65585-abbott-architect-c-peptide-calibrator-recall-mexico-license-error.

Source Summary by GovInfoNow · govinfonow.com/recall/65585-abbott-architect-c-peptide-calibrator-recall-mexico-license-error · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1894-2020

Cite this page

“Abbott ARCHITECT C Peptide Calibrator Recall: Mexico License Error.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65585-abbott-architect-c-peptide-calibrator-recall-mexico-license-error. Based on FDA recall #Z-1894-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1894-2020%22&limit=1).

The FDA announced on April 1, 2020, that Abbott Laboratories is recalling ARCHITECT C Peptide Calibrators due to an error in the renewal documentation process for a license in Mexico. The company is recalling all in-date reagents, calibrators, and controls until a new license is obtained.

How to tell if you have it

  • Brand: Abbott
  • Product: ARCHITECT C Peptide Calibrator
  • Lot Number: 03619E000
  • Expiration Date: 08APR2020

The hazard

The recall is due to an error in the renewal documentation process for a license in Mexico. The ARCHITECT C Peptide Calibrator is used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion, including diabetes mellitus.

Context

GovInfoNow's records show Abbott Laboratories has 33 other recalls on record since May 14, 2012. Other recent recalls include a Class I recall for FreeStyle Libre 14 Day Sensors by Abbott Diabetes Care (Nov. 24, 2025) and a correction for the Alinity ci-series System Control Module (Nov. 13, 2025). Medline also issued recalls on Feb. 25, 2026, rescinding 510(k) clearances for Angiography Kits and Syringes.

How to tell if you have this one

Check for lot number 03619E000 with expiration date 08APR2020 on the ARCHITECT C Peptide Calibrator. The product is used for diabetes testing in patients with abnormal insulin secretion.

  • Brand
    Abbott
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    International distributed only in Mexico, no US distribution.
Recall numberProduct, codes & lots
Z-1893-2020ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.; Lot Numbers 01719F000 (Exp Date 14MAY2020), 02519E000 (Exp Date 09APR2020)
Z-1894-2020ARCHITECT C Peptide Calibrator - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.; Lot Numbers 03619E000, Exp Date 08APR2020
Z-1895-2020ARCHITECT C Peptide Calibrator - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.; Lot Numbers 01819G000, Exp Date 12JUN2020
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the calibrator to confirm if it's affected.

How this recall unfolded

Recall timeline

FDA terminated this recall 5 months after the firm started it.

1. Firm started the recall: Apr 1, 202012. FDA classified it Class III: May 5, 202023. Published in FDA’s Enforcement Report: May 13, 202034. FDA terminated the recall: Sep 1, 202042020
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Abbott recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1894-2020 (April 1, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1894-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA